logo-loader
NASDAQ:NVAX

Novavax, Inc.

Receive alerts
Market:
NASDAQ
Price
4.85 USD
Day Change
2.97%
Market Cap:
$678.77 m
52 weeks high
11.35
52 weeks low
3.54

In brief

Novavax is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology.